Home
Guidelines
Pathogens
Antimicrobials
Staphyloccocus aureus
MRSA Risk Factors:
Evidence of MRSA infection elsewhere
Nasal colonization with MRSA
Injection drug use
GAS
Gram negative organisms
Including Pseudomonas aeruginosa
Piperacillin-tazobactam 4.5g IV Q6H
ADD
Vancomycin (Dosing Below)
Adults
Vancomycin 15-20mg/kg Q8-12H
Pediatrics
Birth to 3 Months Vancomycin 15mg/kg IV Q6H
Over 3 Months Vancomycin 10mg/kg IV Q6H